CompletedPHASE1, PHASE2NCT01146197

Input of the Use of Indometacin in Gitelman Syndrome as Compared to Potassium Sparing Diuretics

Studying Gitelman syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Assistance Publique - Hôpitaux de Paris
Principal Investigator: Blanchard Anne, MD,PhD
APHP
Intervention: TREATMENT(drug)
Enrollment: 33 enrolled
Eligibility: 18-60 years · All sexes
Timeline: 2010 – 2013

Study locations (1)

Hopital Européen Georges Pompidou, Paris, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01146197 on ClinicalTrials.gov

Other trials for Gitelman syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06922370
The Osteoarticular Manifestations in Patients With Gitelman Syndrome
Second Affiliated Hospital, School of Medicine, Zhejiang University

See all trials for Gitelman syndrome →

← Back to all trials